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Abstract
Urgent reoperative transapical aortic valve-in-valve has never been proposed as a treatment option in case of a failed transcatheter aortic
valve implantation (TAVI) or in case of worsening of an existing paravalvular leak, if this complication occurs right after, or a few days after,
the primary transapical aortic valve implantation. Experienced surgeons should argue that after a transapical TAVI, the apex is damaged
and fragile, with a high risk of irreparable ventricular tears and life-threatening bleeding if a second transapical procedure is scheduled
during the acute phase. Nevertheless, if the patient is inoperable and the vascular status, including the ascending aorta, limits alternative
accesses, the urgent reoperative transapical valve-in-valve becomes an alternative. We illustrate, for the ﬁrst time ever, our experience with
an 81-year old female patient who underwent a transapical (TA) TAVI with a Sapien™ XT 23 mm. The day after the procedure, the patient
haemodynamically worsened in combination with a worsening of a known (grade 1–2) paravalvular leak. Thus, on postoperative day two,
an urgent transapical valve-in-valve was performed, and a second Sapien™ XT 23 mm was placed, with an excellent haemodynamic result
and absence of leak. The redo apical access did not appear very complicated and the postoperative recovery was uneventful.
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INTRODUCTION
Transapical transcatheter aortic valve implantation (TA-TAVI) is
performed in high-risk patients with severe vascular disease.
However, leaﬂet calciﬁcations, valve malpositioning or a wrong
valve sizing can be at the origin of post-deployment paravalvular
leaks (single or multiple jets) severely affecting the patient
outcome (if equal or above grade 2) [1–4]. In the future, stent-
valves will be speciﬁcally designed to prevent this complication,
whereas today, we can only proceed with repeated valvuloplasties
or valve-in-valve procedures during the same session [1]. Leftover
grade 1 paravalvular regurgitation is widely accepted in the TAVI
community, but sometimes, and for uncertain reasons, this can
worsen postoperatively. Alternatively, the degree of the regurgita-
tion was underestimated and the patient presented a worsening
of his haemodynamic status during the recovery. Thus, if a
repeated valvuloplasty was already performed intraoperatively,
other options are welcome. Redo transapical valve-in-valve for
worsening of a paravalvular leak occurring right after, or a few
days after, the primary TA-TAVI is traditionally not recommended
and, consequently, the patient is sent to high-risk standard
surgery. In fact, if a second TA-TAVI is performed in the acute
phase, the apex is supposed to be damaged and fragile, with a
high risk of irreparable ventricular tear and life-threatening
bleeding. However, if the patient is inoperable and the vascular
status impedes alternative accesses, the urgent transapical is the
only option. We illustrate for the ﬁrst time ever, a case of redo
TA-TAVI performed two days after the ﬁrst procedure.
CASE REPORT
We report the case of an 81-year old female patient suffering from
severe symptomatic aortic valve stenosis and at high risk of stand-
ard surgery (logistic EuroSCORE 1: 23% with vascular disease,
chronic pulmonary disease, age and female gender), with a clinical
fragile proﬁle. The annulus and the valve were heavily calciﬁed
(annulus diameter: 21.5 mm at CT scan and 21.5–22 mm at trans-
oesophageal echocardiogram). The preoperative assessment also
showed a severe calciﬁed aorta with stenosis at the iliac bifurca-
tion and presence of calciﬁcations in the ascending aorta and
aortic arch. The TAVI team performed a transapical TAVI and a
‘stiff’ 23 mm Sapien™ XT was correctly placed under ﬂuoroscopic
and echocardiographic guidance (Fig. 1A). Then, the transoeso-
phageal echocardiogram revealed the presence of a grade 2 para-
valvular regurgitation (near the mitral leaﬂet) that was treated with
a valvuloplasty (with 1 ml more of contrast): this procedure was at
risk of aortic rupture because of the heavy calciﬁcations, and the
regurgitation did not disappear but ameliorated (grade 1–2). Thus,
we accepted the persistence of a mild leak. The patient was extu-
bated and transferred to the intermediate care unit with stable
haemodynamic status. The day after, the haemodynamic status
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deteriorated with a concomitant lowering of the diastolic pres-
sures. Owing to this worsening of haemodynamic parameters, an
echocardiographic control was performed and showed a second
jet and the worsening of the ﬁrst one with suspicion of an under-
estimated moderate paravalvular leak caused by heavy calciﬁca-
tions and a stent-valve position slightly ‘too low’ (but the valve did
not migrated, apparently) (Fig. 2A). Considering the patient’s critical
status and her frailty, the standard valve surgery was not a valid
option. Therefore, we decided to perform a reoperative TA-TAVI for
valve-in-valve: two days after the ﬁrst procedure, we re-performed
the TA-TAVI through the same intercostal space and the same
apical access: a second 23-mm Sapien™ XT was successfully
deployed within the ﬁrst one, 4 mm higher (Fig. 1B). The result
was excellent (14/7 mmHg of gradient) without relevant leak
(Fig. 1C). From a surgical point of view, the apex presented unex-
pected solid tissues and we safely prepared two new purse-string
sutures (Fig. 2C) around the old ones. When the ﬁrst sutures were
catted, there was no bleed and, therefore, we placed the needle,
the guidewires and the Ascendra+™ delivery system as in standard
TA-TAVI (Fig. 2D and E). This was unexpected but it can represent
the result of the routine use of ﬁbrin glue applied on top of the
apex at the end of all TA-TAVI performed in our institution. At the
end of the procedure, the purse-string sutures were tied without
complications (Fig. 2F). The postoperative recovery was uneventful
and the patient left the hospital 8 days later.
DISCUSSION
A case of transapical redo for valve-in-valve has already been
described after a period of 3 years from the ﬁrst TA-TAVI proced-
ure [5]. However, if this performance is required during the acute
phase following the primary TA-TAVI procedure, the redo transa-
pical TAVI is traditionally not recommended and, to the best of
our knowledge, no clinical reports are available in the literature.
In fact, the tissues are supposed to be very fragile with a concrete
risk of apical rupture and poor patient outcome. Thus, in case of
failed or defective TA-TAVI with persistent leak, the percutaneous
re-valvuloplasty of the stent-valve represents the ﬁrst treatment
option, whereas the standard open-heart surgery (still at high
risk) can be performed in urgency if the haemodynamic
status deteriorates rapidly. With the present clinical report we
present, for the ﬁrst time ever, a successful redo TA-TAVI for
valve-in-valve performed two days after the primary TA-TAVI in a
fragile patient.
What we learnt is that a TA-TAVI can be re-performed in
urgency, already a couple of days after the ﬁrst transapical pro-
cedure, with low surgical risk and excellent results. In our experi-
ence, the fragile lady was at high risk for standard surgery and,
therefore, we were obliged to explore this option: the apical
tissue was unexpectedly normal and the apical access was
already sealed. In this scenario, we believe that the use of the
ﬁbrin glue on the top of the apex at the end of all TA-TAVI helps
in securing the access site and, therefore, in preventing bleedings
and the pseudoaneurysm formation. With regard to the tissue
quality, the manipulated apical wall accepted two new purse-
string sutures that were gently tied at the end of the procedure
without need for rapid cardiac pacing. In conclusion, the urgent
redo TA-TAVI for valve-in-valve is a valid transcatheter option
after a failed TA-TAVI if alternatives are unavailable or at too high
risk.
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Figure 1: Intraoperative ﬂuoroscopic images: (A) at the time of the ﬁrst transa-
pical TAVI, the paravalvular leak grade 1 (arrow) is the result of a repeated valvu-
loplasty with an additional 1 ml of contrast in the balloon; (B) the repeated
urgent transapical-TAVI valve-in-valve for worsening of the paravalvular leak
(grade 2); (C) the ﬁnal result.
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Figure 2: (A and B) Echocardiographic views of the paravalvular leak after the ﬁrst TA-TAVI (A) and after the redo TA-TAVI (B) (intragastric LVOT views: 130°. LV: left
ventricle, RV: right ventricle, AO: aorta); (C, D and E) the surgical ﬁeld with the insertion of the guidewire, the pigtail and the delivery system; (F) the ﬁnal result.
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